[结核病抗生素治疗的进展]
Thomas Maitre1, Lorenzo Guglielmetti2, Jérôme Robert2
1AP-HP. Sorbonne Université, Centre national de référence des mycobactéries et de la résistance des mycobactéries aux antituberculeux, Paris, France. Département de pneumologie, centre de référence des maladies rares pulmonaires, AP-HP. Sorbonne Université, Paris, France.
La Revue du praticien
|March 29, 2024
概括
新的抗生素疗法正在缩短对药物敏感性和多药耐药结核病的治疗时间. 基于疾病严重程度的个性化治疗计划为结核病护理提供了进一步的进步.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 治疗传统上需要长时间的治疗,这对患者的坚持和耐药性构成了挑战.
- 耐多药结核病 (MDR-TB) 是一个重大的全球卫生挑战,有效的治疗选择有限.
研究的目的:
- 审查抗生素治疗对药物敏感性和多药耐药结核病的最新进展.
- 突出新的治疗方案和个性化治疗策略.
主要方法:
- 审查目前的临床试验和结核病治疗的治疗指南.
- 分析新的抗结核药物,包括贝达基林,线索利德,德拉曼尼德/普雷托曼尼德和莫西弗洛克萨辛.
- 根据药物治疗方案和疾病特征评估治疗时间的减少.
主要成果:
- 4个月的利法丁和莫西弗洛克萨治疗方案显著减少了对药物敏感结核病的治疗时间.
- 新的药物组合 (bedaquiline,linezolid,delamanid/pretomanid,moxifloxacin) 显示有可能将MDR-TB治疗时间从20个月缩短到6个月.
- 包括疾病程度和细菌负担在内的个性化治疗策略允许治疗持续时间可变.
结论:
- 最近的进展为结核病提供了更短,更个性化的治疗选择.
- 新型抗生素组合正在改变对药物敏感和多药耐药结核病的治疗方法.
- 未来的结核病治疗可能将涉及基于个体患者和疾病因素的量身定制方法.
相关概念视频
01:28Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
01:26Pulmonary Tuberculosis IV
142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
01:29Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
01:28Pulmonary Tuberculosis II
228
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
228
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:31Pulmonary Tuberculosis III
325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
325